Company / Shareholders' Equity
Savara Inc Shareholders' Equity History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$171.4M
FY2024
5-year range
$64.4M / $171.4M
FY2020-FY2024
Trend
+22.1%
vs FY2023
Sector context
#158 of 213
Health Care
What the data says
At $171M, Savara Inc's shareholders' equity ranks #158 of 213 in the Health Care sector. Shareholders' Equity has fluctuated over the past 10 years, ranging from -$36M in FY2016 to $171M in FY2024.
Based on SEC 10-K filings.
$171M in FY2024 with a 5-year CAGR of +9.6%.
Improved from $108M to $171M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +5.9%
- 5-Year CAGR
- +9.6%
- 10-Year CAGR
- -
Sector benchmark
#158 of 213 in Health CareTop 74% of 213This company $171.4M Sector average $2.5B
▼
-93.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.6%, indicating consistent growth.
- In FY2024, shareholders' equity increased 22.1% year-over-year.
- Ranks #158 out of 213 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $171.4M | +22.1% |
| FY2023 | $140.4M | +30.2% |
| FY2022 | $107.8M | -25.4% |
| FY2021 | $144.5M | +124.4% |
| FY2020 | $64.4M | -40.5% |
| FY2019 | $108.2M | +0.0% |
| FY2018 | $108.2M | -9.3% |
| FY2017 | $119.3M | +432.6% |
| FY2016 | -$35.9M | -31.3% |
| FY2015 | -$27.3M | -49.3% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026